Published in Arch Gen Psychiatry on July 01, 1998
Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol (2008) 3.86
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. JAMA Pediatr (2013) 1.47
Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am (2008) 1.10
Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology. J Autism Dev Disord (2000) 1.06
Antipsychotics in the treatment of autism. J Clin Invest (2008) 1.06
Medications for adolescents and young adults with autism spectrum disorders: a systematic review. Pediatrics (2012) 1.04
A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord (2006) 0.93
Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry (2007) 0.92
Off-label indications for atypical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry (2004) 0.92
A prospective open-label study of aripiprazole in fragile X syndrome. Psychopharmacology (Berl) (2011) 0.90
Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord (2006) 0.90
DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families. Behav Brain Funct (2012) 0.88
Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice. Autism Res (2014) 0.87
Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin Neurosci (2012) 0.86
Paliperidone for irritability in adolescents and young adults with autistic disorder. Psychopharmacology (Berl) (2012) 0.83
Use of functional analysis methodology in the evaluation of medication effects. J Autism Dev Disord (2003) 0.83
Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study. Eur Child Adolesc Psychiatry (2008) 0.82
Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study. Front Psychiatry (2016) 0.82
Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults. Neuroimage Clin (2013) 0.81
Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder. Prim Care Companion J Clin Psychiatry (2005) 0.81
Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome? Ann Gen Psychiatry (2015) 0.79
Clinical approach to motor stereotypies in autistic children. Iran J Pediatr (2010) 0.77
Aripiprazole treatment of Asperger's syndrome in the acute psychiatric setting: case report. Neuropsychiatr Dis Treat (2007) 0.76
Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. PLoS One (2016) 0.76
Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders. J Child Adolesc Psychopharmacol (2014) 0.75
The irony of autism. Arch Gen Psychiatry (1998) 0.75
Aggression in autism spectrum disorder: presentation and treatment options. Neuropsychiatr Dis Treat (2016) 0.75
Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study. Indian J Psychol Med (2014) 0.75
Template to Perpetrate: An Update on Violence in Autism Spectrum Disorder. Harv Rev Psychiatry (2016) 0.75
5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study. Brain Res Bull (2011) 0.75
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry (1989) 16.61
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry (1989) 6.98
The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry (1989) 6.80
Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry (2000) 4.49
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry (1990) 3.57
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med (2001) 2.83
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J (1999) 2.72
Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry (2001) 2.59
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry (2000) 2.48
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Silent victims. Children who witness violence. JAMA (1993) 2.26
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol (1999) 2.21
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry (1991) 2.17
Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet (2000) 2.15
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation (2000) 2.07
Garden bird mortalities. Vet Rec (1995) 2.06
A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry (1996) 2.04
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry (1994) 2.04
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis. Cathet Cardiovasc Diagn (1996) 2.03
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation (1994) 1.98
Premonitory urges in Tourette's syndrome. Am J Psychiatry (1993) 1.95
A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry (2001) 1.95
Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry (2000) 1.94
A normed study of face recognition in autism and related disorders. J Autism Dev Disord (1999) 1.94
Speech and prosody characteristics of adolescents and adults with high-functioning autism and Asperger syndrome. J Speech Lang Hear Res (2001) 1.91
Symptoms of obsessive-compulsive disorder. Am J Psychiatry (1997) 1.88
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry (1986) 1.83
Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant (2015) 1.76
Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry (1993) 1.69
Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology (1993) 1.68
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry (1989) 1.66
A twin study of Tourette syndrome. Arch Gen Psychiatry (1985) 1.65
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. J Am Coll Cardiol (1998) 1.61
Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry (1980) 1.59
Goose parvovirus in England and Wales. Vet Rec (2004) 1.57
Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry (1990) 1.56
Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry (1994) 1.56
Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study. J Am Acad Child Adolesc Psychiatry (1997) 1.54
The treatment of Tourette's syndrome: multimodal, developmental intervention. J Clin Psychiatry (1998) 1.54
Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation (2000) 1.54
Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior. J Nerv Ment Dis (1999) 1.52
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry (1995) 1.52
Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology (1998) 1.51
Comorbid association of autism and schizophrenia. Am J Psychiatry (1991) 1.49
Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry (1992) 1.49
Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology (1992) 1.48
Surveillance for West Nile virus in British birds (2001 to 2006). Vet Rec (2008) 1.47
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest (1993) 1.46
Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorders. Br J Psychiatry (1994) 1.46
A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol (1991) 1.45
A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry (2000) 1.44
The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology (1999) 1.44
Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart (1996) 1.43
Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med (1987) 1.42
Social deficits in autism: an operational approach using the Vineland Adaptive Behavior Scales. J Am Acad Child Adolesc Psychiatry (1987) 1.41
Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry (1996) 1.41
Rapid detoxification from opioid dependence. Am J Psychiatry (1989) 1.40
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials. Catheter Cardiovasc Interv (2000) 1.39
Prevalence and predictors of persistent health status impairment in patients referred to a vascular clinic with intermittent claudication. Eur J Vasc Endovasc Surg (2011) 1.39
Rotational atherectomy or balloon angioplasty in the treatment of intra-stent restenosis: BARASTER multicenter registry. Catheter Cardiovasc Interv (2000) 1.39
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence. J Med Chem (2000) 1.35
Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry (1987) 1.35
Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci (1987) 1.31
Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety (1997) 1.31
Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry (2001) 1.30
Familial pattern of Gilles de la Tourette syndrome. Arch Gen Psychiatry (1980) 1.30
Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am J Hum Genet (1996) 1.29
Mothers' functioning and children's symptoms 5 years after a SCUD missile attack. Am J Psychiatry (2001) 1.28
Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry (2000) 1.28
Death without warning? A clinical postmortem study of suicide in 43 Israeli adolescent males. Arch Gen Psychiatry (1993) 1.28
Field endotracheal intubation by paramedical personnel. Success rates and complications. Chest (1984) 1.28
An evaluation of the Autism Behavior Checklist. J Autism Dev Disord (1988) 1.27
A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry (1995) 1.27
8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Bioorg Med Chem Lett (2001) 1.25
Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry (1994) 1.22
Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry (1981) 1.21
Early parental preoccupations and behaviors and their possible relationship to the symptoms of obsessive-compulsive disorder. Acta Psychiatr Scand Suppl (1999) 1.20
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry (1998) 1.19
Israeli preschool children under Scuds: a 30-month follow-up. J Am Acad Child Adolesc Psychiatry (1997) 1.19
Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry (1997) 1.18
Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry (1990) 1.17